Transo Revenue and Competitors
Estimated Revenue & Valuation
- Transo's estimated annual revenue is currently $4.9M per year.
- Transo's estimated revenue per employee is $213,500
Employee Data
- Transo has 23 Employees.
- Transo grew their employee count by -12% last year.
Transo's People
| Name | Title | Email/Phone |
|---|
Transo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $18.7M | 68 | -1% | N/A | N/A |
#2 | $371.1M | 869 | 14% | N/A | N/A |
#3 | $23.8M | 78 | 8% | N/A | N/A |
#4 | $468.4M | 1074 | -2% | $7M | N/A |
#5 | $36.9M | 121 | 1% | N/A | N/A |
#6 | $71.1M | 212 | 9% | N/A | N/A |
#7 | $50.7M | 151 | -4% | N/A | N/A |
#8 | $2632M | 6164 | 15% | N/A | N/A |
#9 | $74.1M | 221 | 13% | N/A | N/A |
#10 | $3.1M | 17 | -6% | N/A | N/A |
What Is Transo?
A collaborative, optimisation and automation technology platform for supply chain stakeholders to efficiently move shipments, while tracking and monitoring in near real-time. Critical and connected solutions offered holistically as a unified platform. Built-to-Adapt, Accelerated 'GO-LIVE' mode, Data Privacy, Ownership & Greater Visibility with End-End Digital Empowerment. Offered with TRANSO SHIELD to help you secure and build resilient operations.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$4.9M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Transo News
Wavelength Pharmaceuticals; Orchid Chemicals & Pharmaceuticals; Otto Brandes Gmbh; Shakti Bioscience; Aspen Biopharma Labs; Hana Pharm; AMGen; Transo-Pharm...
"Eu sentia tanta vergonha. Vergonha da ideia das pessoas saberem que eu transo, ou com quem eu transo". Trending Histórias.
Ela é só mais uma das minhas qualidades e hoje, talvez, eu seja uma mulher de fato, gostosa, porque hoje eu transo de fato com prazer.
Other Companies in Bangalore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 23 | 0% | N/A |
#2 | $2.4M | 23 | -8% | N/A |
#3 | $2.3M | 23 | -26% | N/A |
#4 | $1.9M | 23 | -21% | N/A |
#5 | $5.3M | 23 | -4% | N/A |